Skip to content
10-Q

Quarterly Report

AN2 Therapeutics, Inc. ANTX

0000950170-25-107301

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 27.33M sh
Shares Diluted Q2 2025 · Jun 30, 2025 30.17M sh
Shares Diluted Q2 2025 · Jun 30, 2025 30.11M sh
Shares Diluted Q2 2025 · Jun 30, 2024 29.82M sh
Shares Diluted Q2 2025 · Jun 30, 2024 29.79M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$18.22M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$31.98M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $18.22M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $21.35M
Stockholders Equity Q2 2025 · Jun 30, 2025 $68.84M
Stockholders Equity Q2 2025 · Mar 31, 2025 $73.33M
Stockholders Equity Q2 2025 · Dec 31, 2024 $81.85M
Stockholders Equity Q2 2025 · Jun 30, 2024 $98.35M
Stockholders Equity Q2 2025 · Mar 31, 2024 $110.6M
Stockholders Equity Q2 2025 · Dec 31, 2023 $124.7M
Total Liabilities Q2 2025 · Jun 30, 2025 $6.98M
Total Liabilities Q2 2025 · Dec 31, 2024 $10.24M
Current Assets Q2 2025 · Jun 30, 2025 $67.52M
Current Assets Q2 2025 · Dec 31, 2024 $86.26M
Total Assets Q2 2025 · Jun 30, 2025 $75.83M
Total Assets Q2 2025 · Dec 31, 2024 $92.09M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.21
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.57
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.48
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.04
Eps Basic Q2 2025 · Jun 30, 2025 −$0.21
Eps Basic Q2 2025 · Jun 30, 2025 −$0.57
Eps Basic Q2 2025 · Jun 30, 2024 −$0.48
Eps Basic Q2 2025 · Jun 30, 2024 −$1.04
Sga Expense Q2 2025 · Jun 30, 2025 $4.02M
Sga Expense Q2 2025 · Jun 30, 2025 $7.86M
Sga Expense Q2 2025 · Jun 30, 2024 $3.73M
Sga Expense Q2 2025 · Jun 30, 2024 $7.37M
Rd Expense Q2 2025 · Jun 30, 2025 $3.2M
Rd Expense Q2 2025 · Jun 30, 2025 $10.89M
Rd Expense Q2 2025 · Jun 30, 2024 $12.15M
Rd Expense Q2 2025 · Jun 30, 2024 $26.8M
Net Income Q2 2025 · Jun 30, 2025 −$6.46M
Net Income Q2 2025 · Jun 30, 2025 −$17.1M
Net Income Q2 2025 · Mar 31, 2025 −$10.65M
Net Income Q2 2025 · Jun 30, 2024 −$14.44M
Net Income Q2 2025 · Jun 30, 2024 −$31.1M
Net Income Q2 2025 · Mar 31, 2024 −$16.62M
Operating Income Q2 2025 · Jun 30, 2025 −$7.22M
Operating Income Q2 2025 · Jun 30, 2025 −$18.75M
Operating Income Q2 2025 · Jun 30, 2024 −$15.88M
Operating Income Q2 2025 · Jun 30, 2024 −$34.18M